Volume 6, Issue 3 (2020)                   IEM 2020, 6(3): 211-217 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

poudineh F, Ahani Azari A, Fozouni L. Incidence of Multidrug-Resistant, Extensively Drug-Resistant, and Pandrug-Resistant Pseudomonas aeruginosa Strains Isolated from Clinical Specimens. IEM 2020; 6 (3) :211-217
URL: http://iem.modares.ac.ir/article-4-44605-en.html
1- Department of Microbiology, Gorgan Branch, Islamic Azad University, Gorgan, Iran
2- Department of Microbiology, Gorgan Branch, Islamic Azad University, Gorgan, Iran , ania_783@yahoo.com
Abstract:   (1638 Views)
Aims: Recently, overuse and misuse of antibiotics have led to the development of multidrug-resistant bacteria and infectious diseases caused by these organisms, increasing morbidity and mortality rate in patients. Pseudomonas aeruginosa as a common Gram-negative pathogen is predominantly responsible for hospital-acquired infections. In this study, the prevalence of multidrug-resistant (MDR), extensively drug-resistant (XDR), and pandrug-resistant (PDR) P. aeruginosa strains isolated from clinical specimens of patients admitted to a teaching hospital in Gorgan, Iran, was determined.
Materials & Methods: Clinical samples of blood, urine, burn wound, eye, and secretions (pleural fluid, tracheal or bronchial aspirates and sputum) were collected from all hospitalized patients during a three-month period from April to June 2019. Using conventional biochemical methods, P. aeruginosa strains were identified, and the antibiotic resistance pattern was determined by Kirby-Bauer disc diffusion method.
Findings: A total of 40 (25.4%) P. aeruginosa strains were isolated from 377 clinical specimens. Most of the P. aeruginosa strains were isolated from wound (35%) and urine (30%) samples. Most of the P. aeruginosa positive samples were recovered from intensive care unit (32.5%) and burn ward (30%). The highest susceptibility was shown to fosfomycin (100%), and the lowest susceptibility was observed to ceftazidime (87.5%), followed by aztreonam (60%). Based on the results, 52.5 and 20% of the isolates were MDR and XDR, respectively. All of the MDR isolates exhibited susceptibility to colistin. No PDR phenotype was observed.
Conclusion: Continuous monitoring of drug resistant strains among clinical isolates of P. aeruginosa must be done to adopt effective strategies to decrease the threat of antimicrobial resistance.

Full-Text [PDF 380 kb]   (452 Downloads)    
Article Type: Original Research | Subject: Bacteriology
Received: 2020/07/19 | Accepted: 2020/09/1 | Published: 2020/08/20

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.